menu
    • menu

    Company profile for Alector

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. At Alector we are forging a new path for overcoming the tremendous burden caused by neurodegenerative diseases. Our approach centers on mining the human genome to identify mutations in immune system genes that increase the risk for these disorders. From there, we are innovating ne...
    Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery. At Alector we are forging a new path for overcoming the tremendous burden caused by neurodegenerative diseases. Our approach centers on mining the human genome to identify mutations in immune system genes that increase the risk for these disorders. From there, we are innovating new drugs that counteract the damage these mutations cause.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AlectorUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    151 Oyster Point Blvd, Suite 300 South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://alector.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alector
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alector Ends Dementia Drug After Ph3 Failure, Cuts 49% Staff
    Alector Ends Dementia Drug After Ph3 Failure, Cuts 49% Staff

    22 Oct 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/alector-scraps-dementia-drug-after-phase-iii-flop-lays-off-49-of-staff

    BIOSPACE
    22 Oct 2025
    Share Share
    Alector’s AbbVie-Partnered Alzheimer’s Program Fails Ph 2
    Alector’s AbbVie-Partnered Alzheimer’s Program Fails Ph 2

    26 Nov 2024

    // BIOSPACE

    https://www.biospace.com/drug-development/alectors-abbvie-partnered-alzheimers-program-fails-phase-ii-triggering-a-17-layoff

    BIOSPACE
    26 Nov 2024
    Share Share
    Alector to Participate in Upcoming Healthcare Conferences
    Alector to Participate in Upcoming Healthcare Conferences

    28 Feb 2024

    // PRESS RELEASE

    https://investors.alector.com/news-releases/news-release-details/alector-participate-upcoming-healthcare-conferences-3

    PRESS RELEASE
    28 Feb 2024
    Share Share
    Alector Reports Fourth Quarter and Full Year 2023 Financial Results
    Alector Reports Fourth Quarter and Full Year 2023 Financial Results

    27 Feb 2024

    // PRESS RELEASE

    https://investors.alector.com/news-releases/news-release-details/alector-reports-fourth-quarter-and-full-year-2023-financial

    PRESS RELEASE
    27 Feb 2024
    Share Share
    Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call
    Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call

    20 Feb 2024

    // PRESS RELEASE

    https://investors.alector.com/news-releases/news-release-details/alector-host-fourth-quarter-and-full-year-2023-earnings-call

    PRESS RELEASE
    20 Feb 2024
    Share Share
    Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
    Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease

    08 Feb 2024

    // PRESS RELEASE

    https://investors.alector.com/news-releases/news-release-details/alector-announces-first-patient-dosed-progress-ad-phase-2

    PRESS RELEASE
    08 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search